Leerink Partners Upgrades Zymeworks (ZYME) to Outperform, 'Time to Get Constructive on ZYME?'

November 7, 2024 6:08 AM EST Send to a Friend
(Updated - November 7, 2024 6:19 AM EST)

Leerink Partners analyst Andrew Berens upgraded Zymeworks (NASDAQ: ZYME) from Market ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login